doi:10.1016/s0022-3476(88)80114-8
Not everyone who wants to lose weight is a suitable candidate for GLP-1 medications
To date, there is no evidence of hepatotoxicity, nephrotoxicity, or cardiac damage in any animal trialseven when administered in extremely high doses
Label: RETATRUTIDE PEN injection, solution
In addition, low IGF-1 subjects in a study were found to possess up-regulated fatty acid metabolism along with down-regulated GLUT-1 gene (in charge of glucose uptake in erythrocytes, brain endothelial cells, eye, peripheral nerve and also responsible for materno-placental glucose transfer) [210]
Pour des informations dtailles et vos questions, vous pouvez nous contacter par E-mail